Parnax Lab

{
  "main_header": {
    "sid": 286243,
    "name": "Parnax Lab",
    "stock_name": "Parnax Lab",
    "full_name": "Parnax Lab Ltd",
    "name_url": "stocks-analysis/parnax-lab",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "137.23",
    "chg": -3.55,
    "chgp": "-2.52%",
    "dir": -1,
    "prev_price": "140.78",
    "mcapval": "",
    "mcap": "Micro Cap",
    "scripcode": 506128,
    "symbol": "PARNAXLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE383L01019",
    "curr_date": "Sep 02, 03:30 PM",
    "curr_time": "19:58 PM",
    "last_traded_at": "Sep 02, 03:30 PM IST",
    "bse_nse_vol": "4.14 k",
    "exc_status": "Active",
    "traded_date": "Sep 02, 2026",
    "traded_date_str": "2026 09 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/parnax-lab-286243-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Parnax Lab Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-4178622",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ParnaxLabLtd_mojoScore_4178622.png",
        "date": "2026-09-02 08:06:28",
        "description": "Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Strong Sell to Sell as of 1 September 2026. This adjustment reflects a complex interplay of technical signals, valuation metrics, financial trends, and overall quality assessments, signalling caution for investors despite some positive price momentum."
      },
      {
        "title": "Parnax Lab Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-is-rated-strong-sell-4177668",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ParnaxLabLtd_mojoScore_4177668.png",
        "date": "2026-09-01 10:10:57",
        "description": "Parnax Lab Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Parnax Lab Ltd Downgraded to Strong Sell Amid Weak Financial and Technical Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-downgraded-to-strong-sell-amid-weak-financial-and-technical-trends-4158928",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ParnaxLabLtd_mojoScore_4158928.png",
        "date": "2026-08-18 08:07:34",
        "description": "Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 17 Aug 2026. This revision reflects deteriorating financial trends, weakening technical indicators, and valuation concerns, signalling caution for investors amid a challenging operating environment."
      },
      {
        "title": "Parnax Lab Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-is-rated-sell-4149989",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ParnaxLabLtd_mojoScore_4149989.png",
        "date": "2026-08-12 10:11:51",
        "description": "Parnax Lab Ltd is rated Sell by MarketsMOJO, with this rating last updated on 20 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "When is the next results date for Parnax Lab Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-parnax-lab-ltd-4140448",
        "imagepath": "",
        "date": "2026-08-06 23:18:23",
        "description": "The next results date for Parnax Lab Ltd is scheduled for 14 August 2026...."
      },
      {
        "title": "Parnax Lab Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-is-rated-sell-by-marketsmojo-4131126",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ParnaxLabLtd_mojoScore_4131126.png",
        "date": "2026-08-01 10:10:36",
        "description": "Parnax Lab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 July 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 01 August 2026, providing investors with the most recent and relevant data to assess the company’s outlook."
      },
      {
        "title": "Parnax Lab Ltd Downgraded to Sell Amid Mixed Fundamentals and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-downgraded-to-sell-amid-mixed-fundamentals-and-technical-signals-4111860",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ParnaxLabLtd_mojoScore_4111860.png",
        "date": "2026-07-21 08:10:04",
        "description": "Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 20 Jul 2026. This revision follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, reflecting a cautious stance despite some positive long-term returns."
      },
      {
        "title": "Parnax Lab Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-upgraded-to-hold-as-technicals-improve-amid-mixed-financials-4100152",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ParnaxLabLtd_mojoScore_4100152.png",
        "date": "2026-07-14 08:08:13",
        "description": "Parnax Lab Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical outlook and valuation metrics despite flat recent financial performance. The upgrade, effective from 13 July 2026, is driven by a combination of bullish technical indicators, attractive valuation relative to peers, stable financial trends, and a consistent return profile that outpaces broader market benchmarks."
      },
      {
        "title": "Parnax Lab Ltd Downgraded to Sell Amid Mixed Technicals and Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-downgraded-to-sell-amid-mixed-technicals-and-flat-financials-4094425",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ParnaxLabLtd_mojoScore_4094425.png",
        "date": "2026-07-09 08:04:54",
        "description": "Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 8 July 2026. This change reflects a combination of flat recent financial performance, mixed technical indicators, and valuation considerations that collectively weigh on the stock’s near-term outlook despite its strong long-term returns."
      }
    ],
    "total": 303,
    "sid": "286243",
    "stock_news_url": "https://www.marketsmojo.com/news/parnax-lab-286243"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Parnax Lab Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges

2026-09-02 08:06:28

Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Strong Sell to Sell as of 1 September 2026. This adjustment reflects a complex interplay of technical signals, valuation metrics, financial trends, and overall quality assessments, signalling caution for investors despite some positive price momentum.

Read full news article

Parnax Lab Ltd is Rated Strong Sell

2026-09-01 10:10:57

Parnax Lab Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and technical outlook.

Read full news article

Parnax Lab Ltd Downgraded to Strong Sell Amid Weak Financial and Technical Trends

2026-08-18 08:07:34

Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 17 Aug 2026. This revision reflects deteriorating financial trends, weakening technical indicators, and valuation concerns, signalling caution for investors amid a challenging operating environment.

Read full news article

Parnax Lab Ltd is Rated Sell

2026-08-12 10:11:51

Parnax Lab Ltd is rated Sell by MarketsMOJO, with this rating last updated on 20 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

When is the next results date for Parnax Lab Ltd?

2026-08-06 23:18:23

The next results date for Parnax Lab Ltd is scheduled for 14 August 2026....

Read full news article

Parnax Lab Ltd is Rated Sell by MarketsMOJO

2026-08-01 10:10:36

Parnax Lab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 July 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 01 August 2026, providing investors with the most recent and relevant data to assess the company’s outlook.

Read full news article

Parnax Lab Ltd Downgraded to Sell Amid Mixed Fundamentals and Technical Signals

2026-07-21 08:10:04

Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 20 Jul 2026. This revision follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, reflecting a cautious stance despite some positive long-term returns.

Read full news article

Parnax Lab Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials

2026-07-14 08:08:13

Parnax Lab Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical outlook and valuation metrics despite flat recent financial performance. The upgrade, effective from 13 July 2026, is driven by a combination of bullish technical indicators, attractive valuation relative to peers, stable financial trends, and a consistent return profile that outpaces broader market benchmarks.

Read full news article

Parnax Lab Ltd Downgraded to Sell Amid Mixed Technicals and Flat Financials

2026-07-09 08:04:54

Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 8 July 2026. This change reflects a combination of flat recent financial performance, mixed technical indicators, and valuation considerations that collectively weigh on the stock’s near-term outlook despite its strong long-term returns.

Read full news article

View All News